Content about Others

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for chronic obstructive pulmonary disease, the agency said Friday.

The FDA announced the approval of Breo Ellipta (fluticasone furoate and vilanterol), a once-per-day inhaler made by GlaxoSmithKline and Theravance for long-term treatment of COPD, which includes chronic bronchitis and emphysema.

CINCINNATI — Kids in child care are not meeting their daily nutritional needs with the snacks they tend to eat, according to a new study.

NEW YORK — Target is beta testing a new app that allows users to save on items and share deals on Facebook.

A Bullseye View, Target's online magazine, announced the introduction of Cartwheel, where people can find offers on products by browsing the system or looking at friends' activites, and add up to 10 of their favorites to a list. Once a red check appears in the corner of the offer card, the item can be purchased, and customers can either print a special barcode from their desktop computers or use their mobile devices in-store to access it.

ISSAQUAH, Wash. — Costco Wholesale Corp.'s sales grew 7% in April over April 2012, the club retailer said Thursday.

Costco reported sales of $7.98 billion for the four weeks that ended Sunday, compared with $7.48 billion during the same period last year. Sales for the 35-week period that ended Sunday were $69 billion, 9% higher than the $63.59 billion recorded last year.

Sales in the United States at continuously open stores since last April increased by 4%, while same-store sales for the 35 weeks that ended Sunday increased 6%.

WASHINGTON — The Drug Enforcement Administration collected more than 371 tons of unused medications last month as part of its sixth annual drug take-back program, the agency said.

PARSIPPANY, N.J. — Declining use overall of healthcare services drove down spending on medicines in the United States by 3.5% per capita last year, according to a new study.

AccentHealth collected data through an online survey conducted from April 16 to 18, 2013. Participants responded via AccentHealth's national, online panel of network viewers, and the survey yielded 698 respondents who were at least 18 years of age.

All data is self-reported and not validated.

Below is the demographic breakdown of the respondents and their behavior:

Gender

REDLANDS, Calif. — Midwestern supermarket chain Hy-Vee is expanding its use of a mapping platform made by geographic information systems firm Esri to aid its real estate decision-making, Esri said Wednesday.

Esri said this would allow Hy-Vee to enhance its site selection, using location analytics that combine demographic and psychographic data.

BUFFALO, N.Y. — New York state's second-largest city has become the first market in which a majority of Rite Aid's stores have been converted to the Wellness format, the retail pharmacy chain announced Wednesday.

WHITEHOUSE STATION, N.J. — Drug maker Merck is seeking regulatory approval for an experimental tablet placed under the tongue that could be used to treat ragweed allergies.

Merck said the Food and Drug Administration accepted a regulatory application for its ragweed pollen sublingual allergy immunotherapy tablet. Ragweed, also known as Ambrosia artemisiifolia, is a major cause of seasonal allergies in the United States. Merck also submitted an application for a similar drug, for Timothy grass pollen allergies, in March.

DEERFIELD, Ill. — Japanese drug maker Takeda Pharmaceutical Co. will buy Fort Collins, Colo.-based vaccine maker Inviragen for up to $250 million, the two companies said Wednesday.